化合物简介
PSI-6130 is an experimental treatment for hepatitis C. PSI-6130 is a member of a class of antiviral drugs known as nucleoside polymerase inhibitors that was created by chemist Jeremy L. Clark. Specifically, PSI-6130 inhibits the hepatitis C virus RNA dependant RNA polymerase called NS5B.
基本信息
中文名称
4-氨基-1-((2R,3R,4R,5R)-3-氟-4-羟基-5-(羟基甲基)-3-甲基四氢呋喃-2-基)嘧啶-2(1H)-酮
英文名称
4-amino-1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one
中文别名
英文别名
2\'-Fluoro-2\'-C-methylcytidine、PSI6130、R-1656、2\'-deoxy-2\'-fluoro-2\'-C-methylcytidine
CAS号
817204-33-4
分子式
C10H14FN3O4
分子量
259.234
精确质量
259.097
PSA
110.6
LOGP
-0.6145
物化性质
外观与性状
浅棕色固体
储存条件
4ºC
合成路线
共找到1条合成路线 >